| 标题 |
EMERALD Phase 3 Trial of Elacestrant Versus Standard-of- Care Endocrine Therapy in Patients With ER+/HER2– Metastatic Breast Cancer: Updated Results by Duration of Prior CDK4/6i in Metastatic Setting
ER+/HER2-转移性乳腺癌患者Elacestrant与标准护理内分泌治疗的EMERALD 3期试验:根据转移性环境中既往CDK4/6i持续时间更新结果
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 |